SMC4 inhibitors belong to a specialized class of chemical compounds that have garnered interest in the field of molecular biology and cell cycle regulation. SMC4, which stands for Structural Maintenance of Chromosomes 4, is a critical component of the cohesin complex, a protein complex that plays a pivotal role in maintaining genomic integrity. The cohesin complex is responsible for ensuring accurate chromosome segregation during cell division and contributes to various cellular processes, including DNA repair and gene regulation. SMC4, as a subunit of this complex, is essential for cohesin's function in mediating sister chromatid cohesion, allowing chromosomes to align properly and separate accurately during mitosis and meiosis. SMC4 inhibitors are designed to interact with SMC4 and modulate its activity, potentially disrupting the normal functioning of the cohesin complex.
The mechanism of action of SMC4 inhibitors typically involves their binding to SMC4, which can result in conformational changes or interference with its interactions within the cohesin complex. By doing so, these inhibitors may disrupt the proper assembly and functioning of the cohesin complex, leading to potential defects in chromosome segregation and other cohesin-related processes. The study of SMC4 inhibitors is of significant importance in the field of cell biology as it provides researchers with a valuable tool to investigate the intricate mechanisms underlying chromosome dynamics and cellular division. Understanding the role of SMC4 and its modulation by SMC4 inhibitors contributes to our knowledge of fundamental cellular processes and genome stability, which is critical for the proper functioning and health of organisms.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, 5-Azacytidine may cause hypomethylation of DNA, which could affect the transcription of genes like SMC4. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D intercalates into DNA, which inhibits RNA polymerase and could decrease the overall mRNA synthesis, potentially affecting SMC4 expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis, which could indirectly lead to decreased levels of proteins, including SMC4, by blocking translation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in protein synthesis; this could reduce the expression of proteins like SMC4. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine can inhibit DNA and RNA synthesis, which could potentially decrease the expression of a broad range of genes, including SMC4. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
By inhibiting the DNA enzyme topoisomerase I, camptothecin can interfere with DNA replication, potentially reducing the expression of genes such as SMC4. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide inhibits topoisomerase II, potentially leading to decreased transcription and replication, which could affect the expression of SMC4. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Mitomycin C acts as an alkylating agent, which could cross-link DNA strands and inhibit DNA synthesis, potentially affecting SMC4 gene expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin is a potent inhibitor of RNA polymerase II; this could lead to decreased mRNA synthesis for genes, potentially including SMC4. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Puromycin causes premature chain termination during protein synthesis, which could indirectly decrease the levels of proteins such as SMC4. | ||||||